February 10, 2026
SOHO Insider Amy DeZern, MD, MHS

Amy DeZern, MD, MHS

Share This Post:

Related Post

FDA
Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, News

FDA removes axi-cel limitations of use for primary CNS

February 10, 2026
SOHO Insider podcast
SOHO Asia 2026, Leukemia, Acute Lymphoblastic Leukemia, News, SOHO Insider Podcast, Society Updates

Dr. DiPersio: Cross-sector partnerships needed to sustain innovation in

February 9, 2026
Close up of virologist's hands in blue gloves adjusting microscope in laboratory, conducting scientific research and analysis. Health care, medicine and science concept.
Cellular Therapy, Leukemia

Orca-T immunotherapy improves QOL, resource use over conventional allogeneic

February 6, 2026
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, News

SOHO 2026 abstract submission is now open

February 5, 2026
hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test
ASH 2025

Triplet therapy shows efficacy, tolerability, and transplant potential in

February 4, 2026
Update
Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, T-Cell Lymphoma, News

FDA approves larger Nelarabine vial size for T-ALL and

February 4, 2026